Indeed, the comparison between CEC and CLC values of FH patients after PCSK9-i treatment and those of a small group of control sera added in our experiments as internal standards suggests that the treatment seems able to retrieve HDL-CEC and serum CLC to normal values. The gene discussed is PCSK9; the disease is familial hyperaldosteronism.